ASSURE Wearable ECG vs Ligence Heart
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if your primary need is continuous, long-term, and remote monitoring of at-risk cardiac patients outside of a clinical setting. This tool is ideal for detecting intermittent cardiac events, filtering motion artifacts for reliable data, and providing alert-based notifications to clinicians for timely intervention.
View ASSURE Wearable ECG →Choose Ligence Heart if…
Choose Ligence Heart if your goal is to significantly enhance the efficiency and accuracy of 2D transthoracic echocardiography analysis and reporting within a clinical environment. This AI-powered platform is best suited for automating view classification, measurements, and report generation, allowing cardiologists and sonographers to streamline their diagnostic workflow and improve disease recognition.
View Ligence Heart →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | Ligence Heart |
|---|---|---|
| Pricing | Unknown | Contact-for-pricing |
| Deployment | The ASSURE system is intended for use by a patient during their normal daily activities primarily in the home or community setting, but also hospitals, medical clinics, healthcare facilities and transport. | Cloud-based; on-premise; hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGTool A emphasizes patient comfort and ease of wear with its SensorFit Garment and Adaptive Patient Intelligence for artifact filtering, directly addressing the user experience for a wearable device. Its mobile application also contributes to intuitive patient interaction.
Clinical Value
Ligence HeartWhile Tool A provides valuable continuous monitoring and trend data, Tool B directly enhances diagnostic efficiency and accuracy by automating complex echocardiography analysis and explicitly offering disease recognition for conditions like heart failure and cardiomyopathy. This provides a more immediate and direct impact on clinical diagnosis.
Pricing & Value
TieBoth tools utilize a 'contact for pricing' model and do not provide specific pricing details or transparent value propositions. Without this information, it is impossible to determine which offers better pricing or overall value.
Enterprise Readiness
Ligence HeartBoth tools are FDA cleared, HIPAA compliant, and have BAAs. However, Tool B explicitly highlights its ability to integrate with existing hospital systems like PACS, EHR, and RIS, and offers flexible deployment options (cloud-based, on-premise, hybrid), which are critical for seamless enterprise adoption.
Innovation
Ligence HeartTool A's wearable technology and artifact filtering are innovative, but Tool B's application of AI to fully automate and enhance the complex analysis and reporting of 2D transthoracic echocardiography, including automated view classification, measurements, and disease recognition, represents a more significant advancement in diagnostic workflow.
Support & Docs
ASSURE Wearable ECGTool A offers a dedicated toll-free helpline for both patients and providers, along with patient FAQs, a patient handbook, and a patient application user manual. This comprehensive, patient-centric support is crucial for a wearable device used directly by patients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | Ligence Heart |
|---|---|---|
| Tool Name | ASSURE Wearable ECG | Ligence Heart |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. | AI-powered web-based platform that automates the analysis and reporting of 2D transthoracic echocardiography. |
| Company | Kestra Medical Technologies | Ligence |
| Core Technology/Methodology | Wearable ECG device with SensorFit Garment, ASSURE Detection Algorithm with Quad Channel Processing, Adaptive Patient Intelligence for motion artifact filtering. | AI-powered automated recognition of echocardiography imaging data, view classification, heart phase prediction, and calculation of measurements. |
| Target Data Type | ECG (Electrocardiogram) | 2D Transthoracic Echocardiography |
| Key Output/Benefit | Continuous heart rate monitoring, automatic episode storage, alert-based notifications, physiologic trend data, clinician review via Kestra CareStation. | Automated analysis and reporting, automated calculation of measurements, disease recognition (Heart failure, cardiomyopathy, pulmonary hypertension, valvular heart diseases), integration with existing systems (PACS, EHR, RIS). |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and Ligence Heart.